Lawmakers grill Mylan CEO over EpiPen price hike

On Capitol Hill, Mylan CEO Heather Bresch strongly defended the EpiPen’s nearly-500 percent price hike, testifying under oath. CBS News reviewed documents the company turned over to lawmakers that showed how much Mylan expected the EpiPen to generate in net sales this year. Vinita Nair reports. Source